- Home
- SISI vs RSLS Comparison
SISI vs RSLS Comparison
Compare SISI & RSLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SISI
- RSLS
- Stock Information
- Founded
- SISI 1997
- RSLS 2002
- Country
- SISI China
- RSLS United States
- Employees
- SISI N/A
- RSLS N/A
- Industry
- SISI Medicinal Chemicals and Botanical Products
- RSLS Medical/Dental Instruments
- Sector
- SISI Health Care
- RSLS Health Care
- Exchange
- SISI Nasdaq
- RSLS Nasdaq
- Market Cap
- SISI 6.5M
- RSLS 5.7M
- IPO Year
- SISI 2016
- RSLS 2007
- Fundamental
- Price
- SISI $5.33
- RSLS $3.20
- Analyst Decision
- SISI
- RSLS
- Analyst Count
- SISI 0
- RSLS 0
- Target Price
- SISI N/A
- RSLS N/A
- AVG Volume (30 Days)
- SISI 279.7K
- RSLS 2.6M
- Earning Date
- SISI 09-29-2025
- RSLS 08-22-2025
- Dividend Yield
- SISI N/A
- RSLS N/A
- EPS Growth
- SISI N/A
- RSLS N/A
- EPS
- SISI N/A
- RSLS N/A
- Revenue
- SISI $9,601,324.00
- RSLS $7,175,000.00
- Revenue This Year
- SISI N/A
- RSLS $52.80
- Revenue Next Year
- SISI N/A
- RSLS N/A
- P/E Ratio
- SISI N/A
- RSLS N/A
- Revenue Growth
- SISI 1133.26
- RSLS N/A
- 52 Week Low
- SISI $4.71
- RSLS $1.87
- 52 Week High
- SISI $852.00
- RSLS $303.25
- Technical
- Relative Strength Index (RSI)
- SISI 30.48
- RSLS 57.37
- Support Level
- SISI $6.10
- RSLS $1.87
- Resistance Level
- SISI $7.15
- RSLS $2.85
- Average True Range (ATR)
- SISI 1.21
- RSLS 0.30
- MACD
- SISI 0.06
- RSLS 0.05
- Stochastic Oscillator
- SISI 0.34
- RSLS 61.01
About SISI Shineco Inc.
Shineco Inc aims to care for a healthy life and improve the quality of life by providing safe, efficient, and high-quality health products and services to society. The company has researched and developed various vitro diagnostic reagents and related medical devices to date, and it also produces and sells healthy and nutritious food.
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.